Masimo (MASI) Financial Analysis & Valuation | Quarter Chart
Masimo (MASI)
MASIPrice: $179.95
Fair Value: 🔒
🔒score
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the p... more
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospi... more
Description
Shares
| Market Cap | $9.42B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Catherine Szyman |
| IPO Date | 2007-08-08 | CAGR | 0.27% |
| Employees | 7,500 | Website | www.masimo.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 3.83% | Total Yield | 3.83% |
MASI chart loading...
Fundamentals
Technicals
| Enterprise Value | $9.75B | P/E Ratio | 44.43 |
| Forward P/E | 26.87 | PEG Ratio | — |
| P/S Ratio | 6.08 | P/B Ratio | 11.99 |
| P/CF Ratio | 40.78 | P/FCF Ratio | 45.46 |
| EPS | $4.05 | EPS Growth 1Y | — |
| EPS Growth 3Y | -32.72% | EPS Growth 5Y | -62.94% |
| Revenue Growth 1Y | -14.42% | Gross Margin | 0.62% |
| Operating Margin | 0.2% | Profit Margin | 0.05% |
| ROE | 0.09% | ROA | 0.05% |
| ROCE | 0.23% | Current Ratio | 2.68 |
| Quick Ratio | 1.45 | Cash Ratio | 0.38 |
| Debt/Equity | 0.62 | Interest Coverage | 10.11 |
| Altman Z Score | 9.77 | Piotroski Score | 8 |